Glaucoma rs pirngadi

8/17/2019 Glaucoma rs pirngadi

1/30

GLAUCOMA

Z A L D I

FAKULTAS KEDOKTERAN

UNIVERSITAS ISLAM SUMATERA UTARA

MEDAN

2014

5/1/16GLAUCOMA

Z A L D I1


2/30

Global causes of VisualImpairment, inclusive ofblindness, as percentage

5/1/16GLAUCOMA

Z A L D I2


3/30

Global causes of blindness aspercentage of global blindness in 2010

5/1/16GLAUCOMA

Z A L D I3


4/30

CATEGORY OF VISUAL ACUITY

5/1/16GLAUCOMA

Z A L D I4


5/30

DEFINITION

• Glaucoma is a o!"ic #u$o!a"%&'%ic% is c%a$ac"#$i(#) *&+

– O!"ic #$,# -*#$s )#a"% o!"ic )isc

)ama.#/

– $o.$#ssi,# ,isual -#l) )##c"

– $#)is!osi. ac"o$ is I"$a ocula$

!$#ssu$# 3IO1 5i.% "#sio .laucoma

2 No$mo "#sio .laucoma

6 Lo' "#sio .laucoma5/1/16 GLAUCOMAZ A L D I 5


6/30

MORTALITY 7 MOR8IDITY

• Glaucoma is "%# "%i$) l#a)i. caus#o *li)#ss i "%# US

• T%# $is9 o *#comi. l#.all& *li) io# # $om o!#:a.l# .laucoma isa!!$o;ima"#l& 20


7/30

EA!I"A#I$"

• FUNDUSCOY

• TONOMETRY

• SLITLAM

• GONIOSCOY

• OCT 3 OTICAL

CO5ERENCE TOMOGRA5Y

5/1/16GLAUCOMA

Z A L D I7


8/30

TONOMETRY

5/1/16 GLAUCOMA

Z A L D I8


9/30

GONIOSCOY

5/1/16 GLAUCOMA

Z A L D I9


10/30

GOLDMAN ERIMETRY

5/1/16 GLAUCOMA

Z A L D I10


11/30

GLAUCOMA

A% &'I!A'( GLA)*$!A

1 O!#:a.l# .laucoma

a $ima$& o!#:a.l# .laucoma

* No$mal:"#sio .laucoma 3lo':"#sio .laucoma

2 A.l#:closu$# .laucoma

a Acu"#

* Su*acu"#

c C%$oic

) la"#au i$is

+% *$"GE"I#AL GLA)*$!A

*% E*$"DA'( GLA)*$!A

5/1/16 GLAUCOMAZ A L D I

11


12/30

AQUEOUS HUMOUR OUTFLOW SYSTEM


12


13/30


13


14/30

E#I$L$G(

• T%$## ac"o$s)#"#$mi# "%# IO + – $o)uc"io %umo$

a?u#ous

– R#sis"ac# "oa?u#ous ou"@o'ac$oss "$a*#cula$m#s%'o$9:caal

sc%l##ms s&s"#m – T%# l#,#l o #!iscl#$al

,#ous !$#ssu$#


14


15/30

CLASSIFICATION


15


16/30

&A#$GE"EI


16


17/30


17


18/30

DIRECT

OPHTHALMOSCOPY


18


19/30

FUNDUSCOY

OPTIC NEUROPATHY

S5AE

DEMARCATION

CU DISC RATIO

CUING 7ECAVATION

S5IFT 7NASALISATION

ATRO5Y


19


20/30


20


21/30

VI)AL -IELD


21


22/30

#.E "$'!AL VI)AL-IELD


22


23/30


23

GLAUCOMAGLAUCOMA Optic Neuropathy VF lo

Neuroprotectio!

OBFIOP

PP BP Sclerotic "acular #all

"aopa$ IOP

Mecha!ical%a$a&e

Neutrophin withdrawal

Stopaxoplasmic

flow

Retina ISCHEMIA

ONH

Retina ISCHEMIA

ONH

Vacular %yre&ulatio!

RGC %eath


24/30

ATOGENESE


24


25/30

$I* "E)'$&A#.(


25


26/30

CONGENITAL GLAUCOMA

– $ima$& + au"osomal Bu,#ill#

– S#co)a$& + T$auma/ u,#i"is/ #o!lasma


26


27/30

VI)AL -IELD


27

No$malGlaucoma

Glaucoma A*solu"# Glaucoma


28/30

RISK FACTORS

• L#,#l o #l#,a"#) IO

• Famil& %is"o$& o .laucoma

• Rac#• A.#

• M&o!ia

• S#;


28


29/30

T5ERAY

DRUGS

8#"a a)$##.i9 *loc9#$s 3"imolol/*#"a;olol/ ca$"#olol/ l#,o*ualol/m#"i!$aolol

5&!#$osmo"ic a.#" 3mai"ol/.l&s#$i

As#"a(olami)

M&o"icum


29


30/30

REFERENCES

• Am#$ica Aca)#m& o O!%"%almolo.&/ Glaucoma/S#c"io 10/ 2011:2012

• Am#$ica Aca)#m& o O!%"%almolo.&/ E;"#$alDis#as# a) Co$#a/ S#c"io / 2011:2012

• K%u$aa AK/ Com!$#%#si,# O!%"%almolo.&/ Fou$"%E)i"io / N#' D#l%i/ N#' A.# I"#$asioal 3!Limi"#) u*lis%#$/ 200

• Vau.%a As*u$&s + G##$al O!%"%almolo.&

1"% E)i"io / Mc G$a': 5ills Com!ai#s / Ma& 200

5/1/16GLAUCOMAZ A L D I

30

Glaucoma rs pirngadi

Documents

Transcript of Glaucoma rs pirngadi